+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Lung Model Market - Global Forecast 2026-2032- Product Image
In Vitro Lung Model Market - Global Forecast 2026-2032- Product Image
Sale

In Vitro Lung Model Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889471
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In Vitro Lung Model Market is projected to reach USD 446.07 Million in 2026. It is expected to continue growing at a CAGR of 14.41%, reaching USD 1,003.85 Million by 2032.

In Vitro Lung Models: Executive Summary and Strategic Context

In vitro lung models recreate selected features of human pulmonary biology outside the body, ranging from two-dimensional cell systems to three-dimensional organoids, tissue-engineered constructs, organ-on-chip platforms, and ex vivo preparations. They support research into respiratory disease, toxicology, drug delivery, infection, and personalized medicine while addressing limitations associated with conventional animal and oversimplified cell models. Their value depends on biological relevance, reproducibility, throughput, regulatory acceptance, and fit with the intended application.

Transformative Shifts Reshaping Pulmonary Model Development

The field is moving toward more physiologically relevant systems that combine multiple lung cell types, vascular or immune components, air-liquid interfaces, mechanical breathing cues, and disease-specific phenotypes. Standardization is becoming increasingly important as laboratories seek comparable protocols, validated readouts, quality controls, and interoperable data. Advances in imaging, microfluidics, biomaterials, stem-cell differentiation, and automated handling are also broadening the range of questions that can be addressed. Adoption is influenced not only by scientific performance, but also by workflow integration, laboratory expertise, biosafety requirements, and the ability to demonstrate reproducible results across sites.

Artificial Intelligence Accelerates Model Design, Readouts, and Translation

Artificial intelligence is contributing to the development of in vitro lung models through image segmentation, automated phenotyping, anomaly detection, assay-quality assessment, and analysis of complex multimodal datasets. Machine learning can help identify subtle morphological or functional responses that are difficult to capture through manual scoring, while computational modeling can support experimental design and interpretation of dose-response relationships. The strongest benefits arise when AI is paired with well-annotated, biologically validated datasets. Persistent challenges include dataset bias, limited cross-platform comparability, opaque model decisions, privacy considerations for donor-derived data, and the need for human review and independent validation.

Regional Insights: Regulatory Alignment and Research Infrastructure Shape Adoption

North America benefits from established biomedical research capacity, strong pharmaceutical and biotechnology activity, and ongoing interest in alternatives or complements to animal testing. Europe is characterized by coordinated research networks, advanced organ-on-chip and tissue-engineering activity, and emphasis on standardization, ethical oversight, and regulatory science. Asia-Pacific combines substantial translational research capacity with rapidly expanding biotechnology ecosystems, with adoption shaped by national funding priorities and manufacturing capabilities. Latin America is developing capacity through academic, clinical, and biotechnology partnerships, while access to specialized equipment and harmonized validation practices remains important. The Middle East is investing selectively in advanced life-science infrastructure and precision medicine, and Africa presents opportunities linked to infectious disease, environmental exposure, and locally relevant pulmonary research, alongside constraints in funding, training, and laboratory access.

Group Insights: Multilateral Priorities Influence Collaboration and Validation

ASEAN economies can benefit from shared research infrastructure, regional disease priorities, and cross-border training in organ-on-chip and tissue-engineering methods. BRICS members offer diverse disease burdens, scientific capabilities, and manufacturing potential, but collaboration depends on compatible standards, data exchange, and access to specialized inputs. The European Union provides a framework for coordinated research, ethical governance, and regulatory dialogue across member states. G7 countries contribute substantial expertise in translational medicine, advanced instrumentation, and validation science. GCC members are strengthening biomedical infrastructure and may use in vitro lung models within precision-health and respiratory-disease programs. NATO countries can support civil, defense, and biodefense research collaboration, particularly for respiratory threats, provided that governance, biosafety, and responsible-use principles remain central.

Country Insights: Diverse Capabilities Create Complementary Opportunities

The United States and Canada offer strong academic, clinical, and biotechnology ecosystems for model development and validation. The United Kingdom, Germany, France, Italy, and Spain contribute extensive biomedical research, engineering, and regulatory-science capabilities, with opportunities to improve cross-laboratory harmonization. China, Japan, South Korea, India, and Australia combine advanced research centers with growing interest in translational and precision approaches, although infrastructure and validation maturity vary by institution. Brazil and Mexico provide important clinical and public-health contexts for respiratory research and can expand capability through academic-industry partnerships. Russia retains relevant scientific expertise, while collaboration conditions, access to technologies, and international research connectivity can affect implementation. Across all countries, local training, quality systems, biosafety, and reproducibility are essential to sustained use.

Action Priorities for Leaders Building Reliable In Vitro Lung Programs

Industry leaders should first define the biological and decision-making question before selecting a model, then establish acceptance criteria for barrier integrity, cellular composition, functional responses, reproducibility, and scalability. They should prioritize orthogonal validation against clinically relevant observations, document donor and protocol variables, and use reference controls to support comparison across laboratories. Partnerships with academic, clinical, engineering, and regulatory stakeholders can accelerate translation, while modular platforms may reduce the cost and complexity of adapting assays to new indications. Organizations should introduce AI only where data quality, explainability, cybersecurity, and human oversight are addressed. Finally, leaders should maintain a staged implementation plan covering biosafety, operator training, supply continuity, data governance, and regulatory engagement.

Research Methodology: Evidence-Based Assessment of the In Vitro Lung Model Landscape

This executive summary uses a structured review framework focused on the scientific, operational, regulatory, and geographic dimensions of in vitro lung models. The assessment considers model formats, biological components, application areas, enabling technologies, validation practices, infrastructure requirements, and barriers to adoption. Regional, group, and country narratives synthesize differences in research ecosystems, public-health priorities, regulatory environments, collaboration structures, and technical capacity. Conclusions are limited to qualitative, evidence-oriented insights and intentionally exclude market estimates, market sizing, market shares, forecasts, and company-specific assessments.

Conclusion: Credibility, Standardization, and Translation Will Define Progress

In vitro lung models are becoming important tools for studying pulmonary biology and improving the relevance of preclinical research. Their long-term impact will depend less on novelty alone than on demonstrated reproducibility, transparent characterization, meaningful clinical correlation, and practical integration into existing workflows. Artificial intelligence, advanced biomaterials, microphysiological engineering, and patient-derived biology can expand capabilities, but each requires rigorous validation. Leaders that combine scientific ambition with quality systems, collaborative standards, responsible data practices, and clear use-case selection will be best positioned to translate these models into dependable research and development decisions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In Vitro Lung Model Market, by Product Type
7.1. Introduction
7.2. Instruments
7.3. Kits & Reagents
8. In Vitro Lung Model Market, by Model Type
8.1. Introduction
8.2. 2D Cell Cultures
8.3. 3D Organoids
8.4. Lung-On-A-Chip
9. In Vitro Lung Model Market, by Cell Source
9.1. Introduction
9.2. Animal-Derived Cells
9.3. Cell Lines
9.4. Human-Derived Cells
9.4.1. Primary Cells
9.4.2. Stem Cell-Derived Cells
10. In Vitro Lung Model Market, by Application
10.1. Introduction
10.2. Disease Modeling
10.3. Drug Discovery & Development
10.4. Personalized Medicine
10.5. Toxicity Testing
11. In Vitro Lung Model Market, by End Users
11.1. Introduction
11.2. Academic & Research Institutes
11.3. CROs
11.4. Pharmaceutical & Biotechnology Companies
11.5. Regulatory Agencies
12. In Vitro Lung Model Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. In Vitro Lung Model Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. BRICS
13.5. European Union
13.6. ASEAN
13.7. GCC
14. In Vitro Lung Model Market, by Country
14.1. Introduction
14.2. China
14.3. United States
14.4. Japan
14.5. India
14.6. Germany
14.7. United Kingdom
14.8. Australia
14.9. France
14.10. South Korea
14.11. Canada
14.12. Italy
14.13. Brazil
14.14. Mexico
14.15. Russia
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AlveoliX AG
16.2. Brainlab AG
16.3. Cn Bio Innovations Limited
16.4. Emulate, Inc.
16.5. Epithelix Sarl
16.6. Hologic, Inc.
16.7. Horizon Discovery Group plc
16.8. Insphero AG
16.9. Lonza Group AG
16.10. Mattek Corporation by Bico Group
16.11. McKesson Corporation
16.12. Merck KGaA
16.13. MICA Information Systems, Inc.
16.14. Mimetas B.V.
16.15. PromoCell GmbH
16.16. STEMCELL Technologies Inc.
16.17. Thermo Fisher Scientific Inc
16.18. Tissuse GmbH
16.19. Varian Medical Systems, Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global In Vitro Lung Model Market, Years Considered for the Study
FIGURE 2. Global In Vitro Lung Model Market, Research Design
FIGURE 3. Global In Vitro Lung Model Market, Research Framework
FIGURE 4. Global In Vitro Lung Model Market, Data Triangulation
FIGURE 5. Global In Vitro Lung Model Market Size, 2017-2032 (USD Million)
FIGURE 6. Global In Vitro Lung Model Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global In Vitro Lung Model Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global In Vitro Lung Model Market Size, by Model Type, 2025 vs 2032 (%)
FIGURE 9. Global In Vitro Lung Model Market Size, by Model Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global In Vitro Lung Model Market Size, by Cell Source, 2025 vs 2032 (%)
FIGURE 11. Global In Vitro Lung Model Market Size, by Cell Source, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global In Vitro Lung Model Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global In Vitro Lung Model Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global In Vitro Lung Model Market Size, by End Users, 2025 vs 2032 (%)
FIGURE 15. Global In Vitro Lung Model Market Size, by End Users, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global In Vitro Lung Model Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global In Vitro Lung Model Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global In Vitro Lung Model Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global In Vitro Lung Model Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global In Vitro Lung Model Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global In Vitro Lung Model Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global In Vitro Lung Model Market Segmentation & Coverage
TABLE 2. Global In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 3. Global In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Kits & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Kits & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Kits & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 11. Global 2D Cell Cultures Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global 2D Cell Cultures Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global 2D Cell Cultures Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global 3D Organoids Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global 3D Organoids Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global 3D Organoids Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Lung-On-A-Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Lung-On-A-Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Lung-On-A-Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 21. Global Animal-Derived Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Animal-Derived Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Animal-Derived Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Cell Lines Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Cell Lines Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Cell Lines Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Human-Derived Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Human-Derived Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Human-Derived Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Primary Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Primary Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Primary Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Stem Cell-Derived Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Stem Cell-Derived Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Stem Cell-Derived Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 37. Global Disease Modeling Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Disease Modeling Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Disease Modeling Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Drug Discovery & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Drug Discovery & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Drug Discovery & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Toxicity Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Toxicity Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Toxicity Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 50. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global CROs Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global CROs Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global CROs Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Regulatory Agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Regulatory Agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Regulatory Agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 70. Europe In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Europe In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. Europe In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 73. Europe In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 74. Europe In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 75. Europe In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. Europe In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 77. North America In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. North America In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 79. North America In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 80. North America In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 81. North America In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 82. North America In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 83. North America In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 84. Latin America In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Latin America In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Latin America In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 87. Latin America In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 88. Latin America In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 89. Latin America In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Latin America In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 91. Africa In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Africa In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. Africa In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 94. Africa In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 95. Africa In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 96. Africa In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Africa In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 98. Middle East In Vitro Lung Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Middle East In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Middle East In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 101. Middle East In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 102. Middle East In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 103. Middle East In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Middle East In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 105. Global In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. NATO In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. NATO In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. NATO In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 109. NATO In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 110. NATO In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 111. NATO In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. NATO In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 113. G7 In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. G7 In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. G7 In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 116. G7 In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 117. G7 In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 118. G7 In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 119. G7 In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 120. BRICS In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. BRICS In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. BRICS In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 123. BRICS In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 124. BRICS In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 125. BRICS In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 126. BRICS In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 127. European Union In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. European Union In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 129. European Union In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 130. European Union In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 131. European Union In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 132. European Union In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. European Union In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 134. ASEAN In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. ASEAN In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. ASEAN In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 137. ASEAN In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 138. ASEAN In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 139. ASEAN In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. ASEAN In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 141. GCC In Vitro Lung Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. GCC In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. GCC In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 144. GCC In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 145. GCC In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 146. GCC In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. GCC In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 148. Global In Vitro Lung Model Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. China In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 150. China In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 151. China In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 152. China In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 153. China In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 154. China In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. China In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 156. United States In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 157. United States In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. United States In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 159. United States In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 160. United States In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 161. United States In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. United States In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 163. Japan In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 164. Japan In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 165. Japan In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 166. Japan In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 167. Japan In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 168. Japan In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Japan In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 170. India In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 171. India In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. India In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 173. India In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 174. India In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 175. India In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. India In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 177. Germany In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 178. Germany In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Germany In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 180. Germany In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 181. Germany In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 182. Germany In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Germany In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 184. United Kingdom In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 185. United Kingdom In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 186. United Kingdom In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 187. United Kingdom In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 188. United Kingdom In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 189. United Kingdom In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. United Kingdom In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 191. Australia In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 192. Australia In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 193. Australia In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 194. Australia In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 195. Australia In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 196. Australia In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Australia In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 198. France In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 199. France In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. France In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 201. France In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 202. France In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 203. France In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. France In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 205. South Korea In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 206. South Korea In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. South Korea In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 208. South Korea In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 209. South Korea In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 210. South Korea In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. South Korea In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 212. Canada In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 213. Canada In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Canada In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 215. Canada In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 216. Canada In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 217. Canada In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. Canada In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 219. Italy In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 220. Italy In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Italy In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 222. Italy In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 223. Italy In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 224. Italy In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 225. Italy In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 226. Brazil In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 227. Brazil In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. Brazil In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 229. Brazil In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 230. Brazil In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 231. Brazil In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Brazil In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 233. Mexico In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 234. Mexico In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. Mexico In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 236. Mexico In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 237. Mexico In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 238. Mexico In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 239. Mexico In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 240. Russia In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 241. Russia In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 242. Russia In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 243. Russia In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 244. Russia In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 245. Russia In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. Russia In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 247. Spain In Vitro Lung Model Market Size, 2017-2032 (USD Million)
TABLE 248. Spain In Vitro Lung Model Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. Spain In Vitro Lung Model Market Size, by Model Type, 2017-2032 (USD Million)
TABLE 250. Spain In Vitro Lung Model Market Size, by Cell Source, 2017-2032 (USD Million)
TABLE 251. Spain In Vitro Lung Model Market Size, by Human-Derived Cells, 2017-2032 (USD Million)
TABLE 252. Spain In Vitro Lung Model Market Size, by Application, 2017-2032 (USD Million)
TABLE 253. Spain In Vitro Lung Model Market Size, by End Users, 2017-2032 (USD Million)
TABLE 254. Global In Vitro Lung Model Market Share, by Key Player, 2025
TABLE 255. Global In Vitro Lung Model Market, Key Experts

Companies Mentioned

  • AlveoliX AG
  • Brainlab AG
  • Cn Bio Innovations Limited
  • Emulate, Inc.
  • Epithelix Sarl
  • Hologic, Inc.
  • Horizon Discovery Group plc
  • Insphero AG
  • Lonza Group AG
  • Mattek Corporation by Bico Group
  • McKesson Corporation
  • Merck KGaA
  • MICA Information Systems, Inc.
  • Mimetas B.V.
  • PromoCell GmbH
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc
  • Tissuse GmbH
  • Varian Medical Systems, Inc

Related Topics

Related Reports

In Vitro Lung Model - Global Strategic Business Report - Product Image

In Vitro Lung Model - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
In Vitro Lung Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

In Vitro Lung Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
In-Vitro Lung Model Market Report 2026 - Product Image

In-Vitro Lung Model Market Report 2026

  • Report
  • 250 Pages
  • Global
From
In Vitro Lung Model Market Outlook 2026-2034: Market Share, and Growth Analysis by Model Type, Application, End User - Product Image

In Vitro Lung Model Market Outlook 2026-2034: Market Share, and Growth Analysis by Model Type, Application, End User

  • Report
  • 160 Pages
  • Global
From
In Vitro Toxicology Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In Vitro Toxicology Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From

About the In Vitro Lung Model Market

The In Vitro Lung Model market is a subset of the In Vitro Diagnostics (IVD) industry. It is composed of products and services used to simulate the human lung in a laboratory setting. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. In Vitro Lung Models are typically composed of a combination of cell cultures, organoids, and 3D printed scaffolds. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. The In Vitro Lung Model market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, PromoCell, Lonza, and Corning. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.